Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

Pages

Shots - Health News
11:03 pm
Wed April 23, 2014

FDA Moves To Regulate Increasingly Popular E-Cigarettes

A woman tries electronic cigarettes at a store in Miami.
Joe Raedle Getty Images

Originally published on Thu April 24, 2014 2:33 pm

The Food and Drug Administration Thursday proposed regulating e-cigarettes for the first time.

The agency unveiled a long-awaited rule that would give it power to oversee the increasingly popular devices, much in the way that it regulates traditional cigarettes.

Read more
Shots - Health News
2:54 pm
Tue April 22, 2014

FDA Advisers Vote Against Approving New Opioid Painkiller

iStockphoto

Originally published on Tue April 22, 2014 8:50 pm

A key government panel Tuesday voted unanimously against approval of a powerful opioid prescription painkiller intended to provide faster relief with fewer side effects.

At the conclusion of a hearing, the Food and Drug Administration advisory committee voted 14-0 against recommending that the agency approve Moxduo, the first drug to combine morphine and oxycodone into one capsule.

Read more
Shots - Health News
2:29 am
Tue April 22, 2014

Powerful Narcotic Painkiller Up For FDA Approval

Morphine and oxycodone (the active ingredient in Oxycontin) are strong narcotic pain relievers on their own. Moxduo, a drug now up for FDA approval, would combine morphine and oxycodone in a single capsule.
Rich Pedroncelli AP

Originally published on Tue April 22, 2014 11:34 am

The Food and Drug Administration is trying to decide whether to approve a powerful new prescription painkiller that's designed to relieve severe pain quickly, and with fewer side effects than other opioids.

While some pain experts say the medicine could provide a valuable alternative for some patients in intense pain, the drug (called Moxduo) is also prompting concern that it could exacerbate the epidemic of abuse of prescription painkillers and overdoses.

Read more
Shots - Health News
2:25 am
Tue April 15, 2014

Voodoo Dolls Prove It: Hunger Makes Couples Turn On Each Other

Volunteers with lower levels of blood sugar stuck more pins in voodoo dolls of their spouses than people with higher levels.
Courtesy of Brad Bushman

Originally published on Tue April 15, 2014 4:03 pm

A lot of us know what can happen when we get hungry. We get grumpy, irritable and sometimes nasty.

There's even a name for this phenomenon: "Hangry, which is a combination of the words hungry and angry," says psychologist Brad Bushman from Ohio State University.

Read more
Shots - Health News
3:18 am
Mon March 17, 2014

Doctors Use 3-D Printing To Help A Baby Breathe

Garrett shares a moment with his mother, Natalie Peterson. "He has been doing so good," she says. "He's been smiling."
Nicole Haley/University of Michigan Health System

Originally published on Mon March 17, 2014 10:59 am

Ever since the day Garrett Peterson was born, his parents have had to watch him suddenly just stop breathing.

"He could go from being totally fine to turning blue sometimes — not even kidding — in 30 seconds," says Garrett's mother, Natalie Peterson, 25, of Layton, Utah. "It was so fast. It was really scary."

Read more

Pages